Synthesis, Crystal Structure and Bioactivities of 1-（4-Chlorophenyl）-3- [ 5-（pyrid-4-yl）- 1,3,4-thiadiazol-2-yl] urea

The title compound 1-(4-chlorophenyl)-3-[5-(pyrid-4-yl)-1,3,4-thiadiazol-2-yl]urea (C14H10ClN5OS, Mr = 331.79) has been synthesized by the reaction of 2-amino-5-(pyrid-4-yl)- 1,3,4-thiadiazole with 4-chlorobenzoyl azide, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to triclinic system, space group P with a = 5.8550(8), b = 7.5668(10), c = 16.416(2) , α = 78.364(2), β = 81.204(2), γ = 84.749(2)°, V = 702.58(16) 3, Z = 2, Dc = 1.568 g/cm3, μ = 0.429 mm-1, F(000) = 340, the final R = 0.0442 and wR = 0.1092 for 2001 observed reflections (I > 2σ(I)). X-ray diffraction analysis reveals that the title molecule is nearly planar. In the crystal structure, the molecules are linked by strong intermolecular N-H…N hydrogen bonds together with weak nonclassical intermolecular (C-H…Y, Y = N, O and Cl) hydrogen bonds and stacked through π-π interactions. The preliminary bioassay shows that the title compound exhibits good fungicidal activities against Rhizoctonia solani, Botrytis cinerea and Dothiorella gregaria.     

Synthesis and Crystal Structure of Isonicotinic Acid [1-（3,5-Dibromo-2- hydroxyphenyl）methylidene]hydrazide Methanol

A new Schiff base compound, C13H9Br2N3O2·CH3OH, isonicotinic acid [1-(3,5- dibromo-2-hydroxyphenyl)methylidene]hydrazide methanol, has been synthesized and characterized by elemental analysis, IR spectra, and single-crystal X-ray diffraction. The compound comprises a Schiff base moiety isonicotinic acid [1-(3,5-dibromo-2-hydroxyphenyl) methylidene]hydrazide and a methanol molecule. The crystal belongs to the triclinic system, space group P1 with a = 8.464(1), b = 9.511(2), c = 10.901(2) , α = 92.940(2), β = 110.456(2), γ = 96.040(2)o, Z = 2, V = 814.0(2) 3, Dc = 1.759 g/cm3, Mr = 431.09, λ(MoKα) = 0.71073 , μ = 4.994 mm-1, F(000) = 424, R = 0.0440 and wR = 0.1061. A total of 3284 unique reflections were collected, of which 2197 with I > 2σ(I) were observed. The molecule adopts a trans configuration about the C=N double bond. The dihedral angle between the benzene and pyridine rings is 22.0(4)o. The crystal structure is stabilized by intermolecular O-H···N and C-H···O hydrogen bonds, forming layers parallel to the ac plane. The preliminary biological tests show that the compound has potential antibacterial activities.     

新型三唑类抗真菌化合物的三维定量构效关系研究

采用比较分子力场分析法(CoMFA)和比较分子相似性指数分析法(CoMSIA), 系统研究了40个新型三唑类化合物抗真菌活性的三维定量构效关系. 在CoMFA研究中, 研究了两种药效构象对模型的影响, 并考察了网格点步长对统计结果的影响. 在CoMSIA研究中, 系统考察了各种分子场组合、网格点步长和衰减因子对模型统计结果的影响, 发现立体场、静电场、疏水场和氢键受体场的组合得到最佳模型. 所建立CoMFA和CoMSIA模型的交叉相关系数q²值分别为0.718和0.655, 并都具有较强的预测能力. CoMFA和CoMSIA模型的三维等值线图直观地解释了化合物的构效关系, 阐明了化合物结构中苯环上各位置取代基对抗真菌活性的影响, 为进一步结构优化提供了重要依据.     

4-[(E)-2-(3,4,5-三甲氧基苯基)乙烯基]苯氧基羧酸酯的合成及抗肿瘤活性研究

二苯乙烯的多种衍生物表现出一系列的生理活性,如3,4,5.三羟基二苯乙烯(白藜芦醇)具有预防心脏病,抑制血小板凝聚,调控脂质和脂蛋白代谢,抗氧化及对癌症的治疗等作用[1-3].     

氟康唑衍生物的设计合成及体外抗真菌活性研究

为了寻找活性更好的抗真菌化合物,基于已有的计算机辅助药物设计结果,保留氟康唑母体结构必需药效团,设计、合成了22个含对甲酚和胸腺嘧啶的氟康唑新衍生物.目标化合物的结构经1H NMR、元素分析和ESI-MS确证,初步体外抗真菌活性试验结果表明,化合物5l对7种真菌都表现出了较好的抗真菌活性(烟曲霉菌除外),化合物5a～5e,5g,5h,7a和7b对不同真菌表现出了一定的抗真菌活性.炔丙基取代氨基侧链结构的引入有利于提高该类目标化合物体外抗真菌活性,值得进一步深入研究.     

苯甲酸-Fenton体系荧光法测定中草药抗氧化活性

利用Feton体系产生羟自由基,能与苯甲酸反应生成具有强荧光的产物,加入抗氧化剂可有效清除羟自由基,导致体系荧光强度降低.据此建立了筛选抗氧化剂的荧光新体系.应用所建立的方法测定了葛根、吴茱萸和黄连三种常见中草药的抗氧化活性.结果表明,当中草药的浓度为0.4 mg(dry weight)/mL时,葛根、吴茱萸、黄连对羟...     

以三唑农药为配体的两个铜配合物的合成、晶体结构与抑菌活性(英文)

由三唑农药烯效唑和多效唑合成了2个铜配合物[CuL14Cl2](1)和[CuL24Cl2·4H2O](2)(L1=uniconazole,L2=paclobutrazol)。通过元素分析、红外光谱和X-ray单晶衍射对其结构进行了表征。结构分析表明,1属三斜晶系,P1空间群,晶胞参数为a=0.895 6(3)nm,b=1.326 7(4)nm,c=1.491 8(4)nm,α=94.828(3)°,β=97.774(3)°,γ=105.280(3)°,V=1.680 8(9)nm3。2属三斜晶系,P1空间群,晶胞参数为a=1.021 89(19)nm,b=1.329(3)nm,c=1.366 4(3)nm,α=81.564(2)°,β=79.508(2)°,γ=79.185(2)°,V=1.785 3(7)nm3。在2个配合物中,六配位的铜离子都采取扭曲的八面体配位构型,分别来自三唑配体的4个氮原子和2个氯原子配位。1和2都由分子间氢键连接成一维链结构。与相应的配体相比,1和2的抑菌活性明显增强。     

Synthesis, Characterization, Spectroscopy and Study of Antimicrobial Properties of Two New Substituted Trichloroaluminate（Ⅲ） Complexes [AlCl3X]- （X = SCN-, CN-）

The synthesis and characterization of two new aluminate(Ⅲ) complexes with general formula K[AlCl3X] are reported. These compounds derived from aluminate trichloride and related salts. Potassium trichlorothiocyanoaluminate, PCTA, and potassium trichlorocyanatoalu-minate, PCCA, are two new ionic aluminate complexes. They can be easily synthesized in a nearly quantitative yield by using the direct reaction of AlCl3 and KX. The complexes were characterized by physico-chemical and spectroscopic methods. Theoretical calculations have been used for the extraction of structural and spectroscopic data of these new synthesized complexes. The antibacterial activities of such compounds were studied against the Staphylococcus aureus, Escherichia coli, Staphylococcus Epidermidis, Estreptococo B and Shigella.     

2-(2,4-二氟苯基)-1-(4-烃基派嗪-1-基)-3-(1,2,4-三唑-1-基)-2-丙醇类化合物的合成及抗真菌活性

近20年来,真菌感染特别是深部真菌感染日益引起人们的广泛关注[1]。三唑类抗真菌药物对真菌的选择性较高,代谢稳定,体内动态、安全性都较好,已成为目前抗真菌药物研究开发的重点[2]。三唑类抗真菌药物是细胞色素P450 14α 去甲基酶的抑制剂,可影响该酶所催化的真菌麦角甾醇的生物合成,导致真菌细胞膜破损而死亡[3,4]。1998年,SynPhar实验室及Taiho制药公司[5]研制开发的化合物Syn 2869采用了取代哌嗪作为侧链。体外实验表明,该化合物抗菌谱广,对多种念珠菌、隐球菌及曲莓菌均有效,体内实验中,与目前临床上治疗真菌感染的主要用药伊曲…     

2-烷氧基-4H-咪唑啉-4-酮衍生物的合成与杀菌活性

应用烯基膦亚胺（1）与芳基异氰酸酯的氮杂Wittig反应，得到的碳二亚胺2再 与醇在醇钠催化下反应，合成了新的2-烷氧基-4H-咪唑啉-4-酮衍生物（3），探讨 了成环反应的条件以及所合成的新型杂环化合物的杀菌活性，结果表明部分化合物 表现出较好的抑菌活性，其中以3b活性最好，在50 mg/L浓度时，对水稻纹枯菌和 苹果轮纹菌的抑制率达81%以上。